Table 3.
Adverse events among health care workers due to personal protective equipment use during the COVID-19 pandemic in the studies included in this systematic review
| Reference | Any adverse event | Dry skin | Pressure injuries | Headache | Dermatitis | Allergy | Rash | Itching | Pain |
|---|---|---|---|---|---|---|---|---|---|
| Zhao et al. 202026 | 838 (87.3) | 199 (20.7) | 516 (53.8) | 146 (15.2) | 162 (16.9) | 222 (23.1) | |||
| Coelho et al. 202027 | 768 (69.4) | 768 (69.4) | |||||||
| Çağlar et al. 202028 | 208 (66.0) | 115 (36.5) | 64 (20.3) | ||||||
| Tabah et al. 202029 | 2169 (80.0) | 1088 (40.1) | 696 (25.7) | ||||||
| Jiang et al. 202030 | 1844 (42.8) | 1293 (30.0) | |||||||
| Hu et al. 202031 | 58 (95.1) | 15 (24.6) | 42 (68.9) | 7 (11.5) | 10 (16.4) | 17 (27.9) | 7 (11.5) | ||
| Ong et al. 202032 | 128 (81.0) | 128 (81.0) | |||||||
| Metin et al. 202033 | 473 (90.1) | 473 (90.1) | 379 (72.5) | 100 (19.1) | 100 (19.1) | ||||
| Guertler et al. 202034 | 34 (85.0) | 32 (82.1) | 13 (32.5) | 6 (15.0) | 8 (20.5) | 12 (30) | |||
| Yildiz et al. 202035 | 507 (91.7) | 507 (91.7) | 410 (74.1) | 494 (89.3) | |||||
| Singh et al. 202036 | 29 (67.4) | 16 (37.2) | 11 (25.6) | 27 (62.8) | 17 (39.5) | 3 (7.0) | 21 (48.8) | 29 (67.4) | |
| Battista et al. 202037 | 168 (90.8) | 54 (29.2) | 118 (63.8) | 93 (50.3) | |||||
| Lin et al. 202038 | 280 (74.5) | 258 (68.6) | |||||||
| Zuo et el. 202039 | 198 (49.0) | 47 (11.6) | 76 (18.8) | 50 (12.4) | 60 (14.9) | 13 (3.2) | |||
| Reference | Hyperhidrosis | Dyspnoea | Others | ||||||
| Zhao et al. 202026 | 593 (61.8) | Skin squeeze; 598 (62.3), dizziness; 555 (57.8), maceration; 142 (14.8), conjunctivitis; 61 (6.4), extreme exhaustion; 598 (62.3) | |||||||
| Coelho et al. 202027 | |||||||||
| Çağlar et al. 202028 | 79 (25.1) | ||||||||
| Tabah et al. 202029 | 1266 (46.7) | Extreme exhaustion; 412 (15.2) | |||||||
| Jiang et al. 202030 | Skin tears; 86 (0.2), moisture-associated skin damage; 465 (10.8) | ||||||||
| Hu et al. 202031 | Skin desquamation; 6 (9.9), moisture-associated skin damage; 16 (26.2) | ||||||||
| Ong et al. 202032 | |||||||||
| Metin et al. 202033 | 75 (14.3) | Stomatitis; 100 (19.1), acne; 207 (39.4) | |||||||
| Guertler et al. 202034 | 5 (12.5) | Asthma; 3 (7.5) | |||||||
| Yildiz et al. 202035 | Constipation; 145 (26.2), urine-related problems; 225 (40.7), nutritional disorders; 257 (46.5), sleep disorders; 309 (55.9), dehydration; 439 (79.4) | ||||||||
| Singh et al. 202036 | 37 (86.1) | Acne; 5 (11.6), nausea; 5 (11.6) | |||||||
| Battista et al. 202037 | 136 (73.5) | Sneezing; 92 (49.7), acne; 79 (42.7), panic attack; 17 (9.2), ocular symptoms; 83 (44.9) | |||||||
| Lin et al. 202038 | Maceration; 199 (52.9), erythema; 227 (60.4) | ||||||||
| Zuo et el. 202039 | Discomfort; 90 (22.3), erythema; 51 (12.6), burning; 15 (3.7) |
Values are expressed as n (%).
Values are expressed as n (%).